Highlights and Quick Summary
- Research and Development (R&D) Expenses Growth for the quarter ending February 28, 2023 was 166.42% (a 39.97% increase compared to previous quarter)
- Year-over-year quarterly Research and Development (R&D) Expenses Growth increased by 254.76%
- Annual Research and Development (R&D) Expenses Growth for 2022 was 71.19% (a -61.03% decrease from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2021 was 182.66% (a -15.05% decrease from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2020 was 215.01% (a -415.03% decrease from previous year)
- Twelve month Research and Development (R&D) Expenses Growth ending February 28, 2023 was 112.63% (a 34.85% increase compared to previous quarter)
- Twelve month trailing Research and Development (R&D) Expenses Growth increased by 49.08% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
| 28 Feb '23 | 30 Nov '22 | 31 Aug '22 | 31 May '22 |
|---|---|---|---|
| 112.63% | 83.52% | 70.33% | 75.55% |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Research and Development (R&D) Expenses Growth of Organigram Holdings Inc.
Most recent Research and Development (R&D) Expenses Growthof OGI including historical data for past 10 years.Interactive Chart of Research and Development (R&D) Expenses Growth of Organigram Holdings Inc.
Organigram Holdings Inc. Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 166.42% | – | – | – | – |
| 2022 | 118.9% | 105.15% | 46.91% | 49.28% | 71.19% |
| 2021 | 67.53% | 221.43% | 482.48% | 75.45% | 182.66% |
| 2020 | -39.18% | -68.89% | -82.83% | -43.0% | 215.01% |
| 2019 | – | – | – | – | -68.25% |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic